Lv11
50 积分 2024-12-17 加入
Abstract CT013: Phase I trial evaluating BNT116, a TAA-encoding mRNA vaccine, in combination with cemiplimab in frail patients with advanced non-small cell lung cancer (NSCLC)
4小时前
求助中
Recent advances in therapeutic cancer vaccines. Nat Rev Cancer. 2025 Jul;25(7):517-533
21天前
已完结
Towards mRNA therapeutics 2.0
1个月前
已完结
ON-O1, an engineered recombinant oncolytic herpes simplex virus type-1, inrecurrent glioma: a single-arm, phase 1/2 study
7个月前
已关闭
T Cell Responses to Individualized Neoantigen TherapymRNA-4157(V940)Alone or in Combination withPembrolizumab in the Phase 1 KEYNOTE-603 Study
7个月前
已完结
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial
7个月前
已完结
皖公网安备34019202002308
